Metraipolis › archive › dc_638037048eac
Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia — Europe PMC PMID:31990962
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31990962
- DOI
- 10.1371/journal.pone.0228217
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-09T14:50:44.171Z
- SHA-256 of the archived text
c9d8ada402ca20656b55487fb840b3922a71fa3e958185baffd9937e9cb6dd72- Stable URL of this page
https://metraipolis.com/documento/dc_638037048eac
How to cite
Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia — Europe PMC PMID:31990962 — Europe PMC (en), https://europepmc.org/article/MED/31990962 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_638037048eac (Metraipolis archive dc_638037048eac, sha256 c9d8ada402ca20656b55487fb840b3922a71fa3e958185baffd9937e9cb6dd72)
BibTeX
@misc{dc638037048eac,
title = {Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia — Europe PMC PMID:31990962},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31990962},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_638037048eac; sha256 c9d8ada402ca20656b55487fb840b3922a71fa3e958185baffd9937e9cb6dd72},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31990962. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Escherichia coli (E. coli) from the B2 phylogenetic group is implicated in colorectal cancer (CRC) as it possesses a genomic island, termed polyketide synthetase (pks), which codes for the synthesis of colibactin, a genotoxin that induces DNA damage, cell cycle arrest, mutations and chromosomal instability in eukaryotic cells. The aim of this study was to detect and compare the prevalence of E. coli expressing pks (pks+ E. coli) in CRC patients and healthy controls followed by investigating the virulence triggered by pks+ E. coli using an in-vitro model. Mucosal colon tissues were collected and processed to determine the presence of pks+ E. coli. Thereafter, primary colon epithelial (PCE) and colorectal carcinoma (HCT116) cell lines were used to detect cytopathic response to the isolated pks+ E. coli strains. Our results showed 16.7% and 4.3% of CRC and healthy controls, respectively were pks+ E. coli. Further, PCE displayed syncytia and cell swelling and HCT116 cells, megalocytosis, in response to treatment with the isolated pks+ E. coli strains. In conclusion, pks+ E. coli was more often isolated from tissue of CRC patients compared to healthy individuals, and our in-vitro assays suggest these isolated strains may be involved in the initiation and development of CRC. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-01-28). Identificativi: PMID 31990962 · PMCID PMC6986756 · DOI 10.1371/journal.pone.0228217. Pagina: https://europepmc.org/article/MED/31990962 — https://doi.org/10.1371/journal.pone.0228217. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-09T14:47:37.633Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.